Task: Answer the multiple choice question.
Query: Which drug exhibits a -18.615% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) CCN1CCN(CCNC(=O)c2ccc(CS(=O)(=O)c3ccccc3C)o2)CC1
b.) O=C(COC(=O)c1cc(S(=O)(=O)N2CCOCC2)ccc1F)c1ccc[nH]1
Answer: b. O=C(COC(=O)c1cc(S(=O)(=O)N2CCOCC2)ccc1F)c1ccc[nH]1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(COC(=O)c1cc(S(=O)(=O)N2CCOCC2)ccc1F)c1ccc[nH]1
O=C(COC(=O)c1cc(S(=O)(=O)N2CCOCC2)ccc1F)c1ccc[nH]1
[2-oxo-2-(1H-pyrrol-2-yl)ethyl] 2-fluoro-5-morpholin-4-ylsulfonylbenzoate